---
layout: page
title: We are recruiting
bigimg:

- "/img/path.jpg"

---

研究内容纲要如下，团队已制定明确的研究计划并已有前期基础，欢迎有兴趣者进一步交流细节和方法。<br>

**1）肾脏纤维化中的损伤型细胞态多样性、代谢调控和临床靶点**<br>

**2）人类肾脏疾病异质性、肾脏损伤修复中的表观遗传因子和分子机制**<br>

**3）新型高通量单细胞和空间多组学技术的开发和应用**<br>
<br>
<hr>

实验室鼓励学科交叉和学科融合，旨在让热爱科学的成员接受扎实的科研训练，掌握组织纤维化、肾脏生物学、分子和细胞生物学的科学知识和技能，学习最前沿的空间组学、单细胞组学、分子代谢等生物技术。<br><br>
**无论你是喜欢在实验台上工作的分子生物学、细胞生物学、生物化学“选手”，还是具有计算和分析经验的生物信息学“选手”，亦或是两者兼备，你的价值在这里都会被珍视。**<br><br>
实验室将帮助成员取长补短、高效获得科研产出，培养成员优秀的科研素养和职业道德，全力支持每个人的职业发展，使其未来成为技能全面、能够独当一面的独立科研工作者。<br><br>
**我们正在积极组建具有优秀科学潜力和合作精神的研究团队，欢迎有意向的同学、青年才俊以及合作者联系。有意加入者请将简历发至邮箱，并简要介绍科研经历和技能。**<br><br>
“莫愁前路无知己，天下谁人不识君。”
<br><br>
<hr>


## About PI:<br>

Dr. Li obtained B.S. in biological sciences from Shanghai Jiao Tong University (Zhiyuan Honors Program) and Ph.D. in molecular genetics and genomics from Washington University in St. Louis. He received postdoctoral training at Yale University Department of Bioengineering.<br>

His research explores mechanisms of kidney injury, fibrosis and metabolic dysregulation with single-cell and spatial genomics approaches, including single-cell transcriptomics, chromatin accessibility and spatially resolved multiomics. In addition, he is broadly interested in epigenetic regulation of gene expression in human diseases, as well as development of cutting-edge genomics technologies.<br>

Since 2020, he has published 9 first-author research articles in journals such as <i>Cell Metabolism</i>, <i>Nature Protocols</i>, <i>Scientific Data</i> and <i>Phenomics</i>, and 6 first-author reviews in <i>Nature Immunology</i>, <i>The Journal of Clinical Investigation</i> and <i>Kidney International</i>. In <i>Cell Metabolism</i> 2022, Li et al. identified novel cell states of injured proximal tubules and dysregulated lipid metabolism in mouse models of kidney fibrosis, featured in the 2023 NIDDK annual report. In <i>Cell Metabolism</i> 2024, Li et al. developed a single-cell multiomics atlas for human kidneys, uncovering region-specific signatures. His work advances understanding of kidney injury and repair mechanisms and development of high-throughput genomics methods. Since 2023, he has been frequently invited as a peer reviewer by journals including <i>Nature Communications</i>, <i>Kidney International</i>, <i>Journal of the American Society of Nephrology</i>, <i>Scientific Reports</i>, and <i>Genomics, Proteomics & Bioinformatics</i>.
